Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

LOTUS EYE HOSPITAL AND INSTITUTE LTD.

NSE : LOTUSEYEBSE : 532998ISIN CODE : INE947I01017Industry : Hospital & Healthcare ServicesHouse : Private

BSE124.151.75 (+1.43 %)

PREV CLOSE ( ) 122.40

OPEN PRICE ( ) 122.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1600

TODAY'S LOW / HIGH ( )120.00 127.00

52 WK LOW / HIGH ( )55.31 140.9

NSE125.033.71 (+3.06 %)

PREV CLOSE( ) 121.32

OPEN PRICE ( ) 119.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 34686

TODAY'S LOW / HIGH( ) 119.00 127.00

52 WK LOW / HIGH ( )54.99 139.2

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 14-03 1997

Management Info

Kavetha Sundaramoorthy - Chairman Sangeetha Sundaramoorthy - Managing Director

Registered Office

Address S F No 770 / 12,Civil Aerodrome Post,Avinashi Road,
Coimbatore,
Tamil Nadu-641014

Phone 0422 4229900 / 99

Email companysecretary@lotuseye.org

Website www.lotuseye.org

Registrars Details

MUFG Intime India Pvt Ltd.

Surya, 35 Mayflower Avenue,Behind Senthil Nagar,Sowripalayam Road,Coimbatore

Listing : BSE, NSE

NEWS

22Sep Lotus Eye Hospital And Institute infor
Lotus Eye Hospital And Institute has informed that the exchange has rece..

28Aug Lotus Eye Hospital And Institute infor
Lotus Eye Hospital And Institute has informed that Annual General meetin..

02Aug Lotus Eye Hospital And Institute submi
Lotus Eye Hospital And Institute has informed that Pursuant to Regulatio..

22May Lotus Eye Hospital and Institute infor
Pursuant to Regulation 29 and other applicable provisions of the SEBI (L..

13Feb Lotus Eye Hospital And Institute infor
Lotus Eye Hospital And Institute has informed that it enclosed Newspaper..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	5.46000000000001	7.40999999999996
Gross Profit	7.31000000000001	13.84
Operating Profit	16.65	47.36
Net Sales	135.17	495.62

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 5235.70 (1.21%)	M.Cap ( in Cr)2530.32
Dr. Lal Pathlabs (BSE) 3137.05 (1.56%)	M.Cap ( in Cr)26280.80
Thyrocare Tech. (BSE) 1396.60 (3.54%)	M.Cap ( in Cr)7409.51
Indraprastha Medical (BSE) 603.90 (2.22%)	M.Cap ( in Cr)5536.13
Yatharth Hospital (BSE) 796.75 (1.14%)	M.Cap ( in Cr)7677.03

Shareholding Pattern

	NON-INSTITUTION	59.36%
	PROMOTERS	40.64%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

LOTUS EYE HOSPITAL AND INSTITUTE LTD.